Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Cross-sectional assessment of the relationships between dyspnea domains and lung function in diffuse parenchymal lung disease.

Londner C, Al Dandachi G, Plantier L, Gillet-Juvin K, Chevalier-Bidaud B, Mahut B, Israel-Biet D, Delclaux C.

Respiration. 2014;87(2):105-12. doi: 10.1159/000351110. Epub 2013 Aug 27.

PMID:
23988331
2.

Diffusing capacity for carbon monoxide is linked to ventilatory demand in patients with chronic obstructive pulmonary disease.

Mahut B, Chevalier-Bidaud B, Plantier L, Essalhi M, Callens E, Graba S, Gillet-Juvin K, Valcke-Brossollet J, Delclaux C.

COPD. 2012 Feb;9(1):16-21. doi: 10.3109/15412555.2011.630700.

PMID:
22292594
3.

Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases.

Pastre J, Plantier L, Planes C, Borie R, Nunes H, Delclaux C, Israël-Biet D.

BMC Pulm Med. 2015 Sep 3;15:100. doi: 10.1186/s12890-015-0084-1.

4.

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.

Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP; Scleroderma Lung Study Group.

Arthritis Rheum. 2005 Feb;52(2):592-600.

5.

Activity-related dyspnea is not modified by psychological status in people with COPD, interstitial lung disease or obesity.

Sanchez O, Caumont-Prim A, Gillet-Juvin K, Callens E, Graba S, Essalhi M, Chevalier-Bidaud B, Israël-Biet D, Mahut B, Delclaux C.

Respir Physiol Neurobiol. 2012 Jun 15;182(1):18-25. doi: 10.1016/j.resp.2012.02.004. Epub 2012 Feb 17.

PMID:
22366153
6.

Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease.

Mahut B, Caumont-Prim A, Plantier L, Gillet-Juvin K, Callens E, Sanchez O, Chevalier-Bidaud B, Bokov P, Delclaux C.

Int J Chron Obstruct Pulmon Dis. 2012;7:165-71. doi: 10.2147/COPD.S29745. Epub 2012 Mar 6.

7.

Factors associated with dyspnea in adult patients with sickle cell disease.

Delclaux C, Zerah-Lancner F, Bachir D, Habibi A, Monin JL, Godeau B, Galacteros F.

Chest. 2005 Nov;128(5):3336-44.

PMID:
16304281
8.

Qualitative aspects of exertional dyspnea in patients with interstitial lung disease.

O'Donnell DE, Chau LK, Webb KA.

J Appl Physiol (1985). 1998 Jun;84(6):2000-9.

9.

Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.

Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K.

Respir Res. 2012 Sep 25;13:85. doi: 10.1186/1465-9921-13-85.

10.

Depression and functional status are strongly associated with dyspnea in interstitial lung disease.

Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR.

Chest. 2011 Mar;139(3):609-616. doi: 10.1378/chest.10-0608. Epub 2010 Aug 5.

PMID:
20688924
11.

Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD.

Wadell K, Webb KA, Preston ME, Amornputtisathaporn N, Samis L, Patelli J, Guenette JA, O'Donnell DE.

COPD. 2013 Aug;10(4):425-35. doi: 10.3109/15412555.2012.758696. Epub 2013 Mar 28.

PMID:
23537344
12.

Effects of obesity on perceptual and mechanical responses to bronchoconstriction in asthma.

Deesomchok A, Fisher T, Webb KA, Ora J, Lam YM, Lougheed MD, O'Donnell DE.

Am J Respir Crit Care Med. 2010 Jan 15;181(2):125-33. doi: 10.1164/rccm.200906-0934OC. Epub 2009 Nov 12.

PMID:
19910609
13.

Physiologic correlates of dyspnea in patients with morbid obesity.

Collet F, Mallart A, Bervar JF, Bautin N, Matran R, Pattou F, Romon M, Perez T.

Int J Obes (Lond). 2007 Apr;31(4):700-6. Epub 2006 Sep 26.

PMID:
17006440
14.

Relation between pulmonary function and 10-year risk for cardiovascular disease among healthy men and women in Italy: the Moli-sani Project.

Arcari A, Magnacca S, Bracone F, Costanzo S, Persichillo M, Di Castelnuovo A, de Curtis A, Zito F, Schünemann HJ, Donati MB, de Gaetano G, Iacoviello L; Moli-sani Investigators.

Eur J Prev Cardiol. 2013 Oct;20(5):862-71. doi: 10.1177/2047487312447904. Epub 2012 May 18.

PMID:
22609891
15.

Repair of giant paraesophageal hernias routinely produces improvement in respiratory function.

Carrott PW, Hong J, Kuppusamy M, Kirtland S, Koehler RP, Low DE.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):398-404. doi: 10.1016/j.jtcvs.2011.10.025. Epub 2011 Nov 20.

16.

The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study.

Launois C, Barbe C, Bertin E, Nardi J, Perotin JM, Dury S, Lebargy F, Deslee G.

BMC Pulm Med. 2012 Oct 1;12:61. doi: 10.1186/1471-2466-12-61.

17.

Determinants of health-related quality of life in patients with pulmonary emphysema.

González E, Herrejón A, Inchaurraga I, Blanquer R.

Respir Med. 2005 May;99(5):638-44. Epub 2004 Nov 11.

18.

[Risk factors for lung toxicity in pediatric cancer survivors].

López Andreu JA, Compte Torrero L, Ferrís Tortajada J, Domenech Clar R, Pérez Tarazona S, Pellicer Porres C, Cortina Orts H, Roqués Serradilla JM.

An Esp Pediatr. 1999 Nov;51(5):505-11. Spanish.

PMID:
10652802
19.

[Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].

Liu QX, Zheng JP, Xie YQ, Guan WJ, Jiang CY, An JY, Yu XX, Liu WT, Gao Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jul;36(7):510-5. Chinese.

PMID:
24262087
20.

Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.

Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T.

Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9.

PMID:
9769280

Supplemental Content

Support Center